Animal Growth Promoters and Performance Enhancers Market

Executive Summary

Animal Growth Promoters and Performance Enhancers Market was valued at US $17.27 billion in 2021 and is projected to grow at 6.63% CAGR over the forecast period to reach US $25.40 billion by 2027. Animal Growth Promoters and Performance Enhancers Market represented US $2.08 billion opportunity over 2019-2021 and estimated to create US $8.12 billion opportunity in 2027 over 2021.

Animal Growth Promoters and Performance Enhancers from Consainsights analyses the Animal Growth Promoters and Performance Enhancers Market in the Life Sciences industry over the forecast period to 2027.

Animal Growth Promoters and Performance Enhancers research report from Consainsights outlines the detailed strategic analysis, trends, market opportunities, growth prospects, industry and market challenges and sustainable solutions to sustain in the competitive environment.

Animal Growth Promoters and Performance Enhancers segmentation includes Type, Animal Type and Geography.

Based on the Type, the Animal Growth Promoters and Performance Enhancers analysis covers Non-antibiotic Growth Promoters And Performance Enhancers, Antibiotic Growth Promoters.

In Type segment, Non-antibiotic Growth Promoters And Performance Enhancers segment has highest cagr growth of 5.88%.

Based on the Animal Type, the Animal Growth Promoters and Performance Enhancers analysis covers Poultry, Swine, Livestock, Aquatic Animals, Other Animals.

In Animal Type segment, Poultry segment has highest cagr growth of 5.88%.

Based on the region, the Animal Growth Promoters and Performance Enhancers analysis covers North America, Europe, Asia-Pacific, Middle-East & Africa, Latin America.

Key companies operating in the market include Cargill, Inc., Royal Dsm N.V., Elanco Animal Health Inc., Merck & Co., Inc., Alltech, Inc., Archer-daniels-midland Company (Adm), Vetoquinol, Bupo Animal Health, Chr. Hansen, Novus International, Inc., Associated British Foods Plc, Erber Ag, Phibro Animal Health Corporation, Kemin Industries, Nutreco (A Wholly Owned Subsidiary Of Shv Group), Basf Se, Lallemand Inc., Bluestar Adisseo Company, Evonik Industries Ag, Land O’lakes, Inc. and so on. This report covers the detailed analysis of the company profiles such as business segments, product portfolio, key brand insights and growth strategies adopted, company SWOT and Strategy analysis along with the financial analysis and analyst insights on the key companies operating in this market.

Market Overview

Definition & Scope

The base currency considered was the US Dollar (USD). Conversion of other currencies to USD was considered on the basis of the average exchange rate for the respective review-period years. The exchange rate conversion for forecast period was determined according to the base year’s conversion rates.

The base year was identified based on the availability of annual reports and secondary information. The base year considered for this study is 2027.

The review period considered for this study is from 2018-2027. The CAGR is for the forecast period, 2022-2027.

Market size estimations for the forecast years were in real terms. Inflation is not part of the pricing, and the average selling price (ASP) was kept constant throughout the forecast period for each country.

Distribution of primary interviews conducted was based on the regional share of the market and the presence of key players in each region.

As a result of data triangulation through multiple methodologies and approaches, the weighted averages of resulting estimates were considered to be the final values.

Currency, Year & Forecast

The currency used in this report is USD, with the market size indicated in terms of USD million/billion.

For companies reporting their revenues in USD, the revenues were taken from their respective annual reports/SEC filings.

For companies reporting their revenues in other currencies, the average annual currency conversion rates were used for a particular year to convert the value to USD Market Definition.

Type

Introduction

In 2021, Non-antibiotic Growth Promoters And Performance Enhancers segment has the highest revenue of US $9.24 billion and is expected to grow at CAGR of 5.88% by 2027 Non-antibiotic Growth Promoters And Performance Enhancers segment has highest cagr growth of 5.88%.

Non-antibiotic Growth Promoters And Performance Enhancers

Non-antibiotic Growth Promoters And Performance Enhancers segment was valued at US $8.12 billion in 2019 and is projected to grow at 5.88% CAGR over the forecast period to reach US $13.58 billion by 2027. Non-antibiotic Growth Promoters And Performance Enhancers segment represented US $1.11 billion opportunity over 2019-2021 and estimated to create US $4.34 billion opportunity in 2027 over 2021.

Antibiotic Growth Promoters

Antibiotic Growth Promoters segment was valued at US $7.07 billion in 2019 and is projected to grow at 5.88% CAGR over the forecast period to reach US $11.82 billion by 2027. Antibiotic Growth Promoters segment represented US $0.97 billion opportunity over 2019-2021 and estimated to create US $3.78 billion opportunity in 2027 over 2021.

Animal Type

Introduction

In 2021, Poultry segment has the highest revenue of US $7.11 billion and is expected to grow at CAGR of 5.88% by 2027 Poultry segment has highest cagr growth of 5.88%.

Poultry

Poultry segment was valued at US $6.26 billion in 2019 and is projected to grow at 5.88% CAGR over the forecast period to reach US $10.46 billion by 2027. Poultry segment represented US $0.86 billion opportunity over 2019-2021 and estimated to create US $3.34 billion opportunity in 2027 over 2021.

Swine

Swine segment was valued at US $3.62 billion in 2019 and is projected to grow at 5.88% CAGR over the forecast period to reach US $6.05 billion by 2027. Swine segment represented US $0.50 billion opportunity over 2019-2021 and estimated to create US $1.94 billion opportunity in 2027 over 2021.

Livestock

Livestock segment was valued at US $2.53 billion in 2019 and is projected to grow at 5.88% CAGR over the forecast period to reach US $4.23 billion by 2027. Livestock segment represented US $0.35 billion opportunity over 2019-2021 and estimated to create US $1.35 billion opportunity in 2027 over 2021.

Aquatic Animals

Aquatic Animals segment was valued at US $1.55 billion in 2019 and is projected to grow at 5.88% CAGR over the forecast period to reach US $2.59 billion by 2027. Aquatic Animals segment represented US $0.21 billion opportunity over 2019-2021 and estimated to create US $0.83 billion opportunity in 2027 over 2021.

Other Animals

Other Animals segment was valued at US $1.23 billion in 2019 and is projected to grow at 5.88% CAGR over the forecast period to reach US $2.06 billion by 2027. Other Animals segment represented US $0.17 billion opportunity over 2019-2021 and estimated to create US $0.66 billion opportunity in 2027 over 2021.